Moderna wins EU nod for combined COVID, flu shot (MRNA:NASDAQ)
Summary
Moderna (MRNA) stock is in focus as the European Commission authorizes mCOMBRIAX, a vaccine designed by the company against COVID-19 and influenza. Read more he...
Description
Moderna (MRNA) stock is in focus as the European Commission authorizes mCOMBRIAX, a vaccine designed by the company against COVID-19 and influenza. Read more he...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source